<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04295395</url>
  </required_header>
  <id_info>
    <org_study_id>AIRS-2017</org_study_id>
    <nct_id>NCT04295395</nct_id>
  </id_info>
  <brief_title>Evaluation of the Brain and Renal Regional Oxygenation Using NIRS in Preterm Infants</brief_title>
  <official_title>Evaluation of the Brain and Renal Regional Oxygenation Using Near Infrared Spectroscopy (NIRS) Method in Very Low Birth Weight (&lt;1500 g) Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vilnius University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vilnius University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the brain and renal oxygenation using near infrared spectroscopy in
      preterm infants with persistent ductus arteriosus
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patent ductus arteriosus (PDA) is common in preterm infants. In the presence of a large PDA,
      significant systemic to pulmonary shunting occurs, which may result in pulmonary
      hyperperfusion and systemic hypoperfusion.

      The evidence on PDA effect on brain and renal tissue oxygenation, measured by Near Infrared
      Spectroscopy is still controversial.

      This study aims to evaluate the brain and renal oxygenation using near infrared spectroscopy
      (NONIN SenSmart model X-100) in 3 groups of preterm infants: 1) closed ductus arteriosus, 2)
      persistent ductus arteriosus, 3) hemodynamicaly significant ductus arteriosus.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 9, 2017</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differences of the mean values of regional oxygenation of the brain and renal</measure>
    <time_frame>from Day 4 of live up to 36 weeks</time_frame>
    <description>Cerebral and renal regional tissue oxygen saturation monitoring on the day after echocardiography was done</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Pre-Term</condition>
  <condition>Persistent Ductus Arteriosus</condition>
  <arm_group>
    <arm_group_label>group1</arm_group_label>
    <description>preterm infant with closed ductus arteriosus, &lt;32 weeks birth weight &lt; 1500g, and &gt; 72 hours of age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group2</arm_group_label>
    <description>preterm infant with PDA &lt; 32 weeks, birth weight &lt; 1500g, and &gt; 72 hours of age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group3</arm_group_label>
    <description>preterm infant with hemodynamically significant PDA &lt; 32 weeks, birth weight &lt; 1500g, and &gt; 72 hours of age</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NONIN SenSmart model X-100 near- infrared spectrometer</intervention_name>
    <description>for to measure cerebral (cSO2) and renal (rSO2 ) regional tissue oxygen saturation on the day after echocardiography was done. The sensors were placed on the right/left forehead and the right/left lateral posterior flank</description>
    <arm_group_label>group1</arm_group_label>
    <arm_group_label>group2</arm_group_label>
    <arm_group_label>group3</arm_group_label>
    <other_name>GE LOGIQ S8 XDclear 2.0 ultrasoud</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Preterm infants with gestation age of &lt; 32 weeks, birth weight &lt; 1500g, &gt; 72 hours of age,
        will have NIRS monitors placed to measure cerebral and renal regional tissue oxygenation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  preterm infants with gestation age of &lt; 32 weeks

          -  birth weight &lt; 1500g

          -  &gt; 72 hours of age.

        Exclusion Criteria:

          -  cardiovascular, renal, cerebral congenital defects,

          -  confirmed sepsis,

          -  no parental consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Weeks</minimum_age>
    <maximum_age>32 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Augustina Jankauskiene, MD</last_name>
    <role>Study Director</role>
    <affiliation>Vilnius University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jurate Navikiene, MD</last_name>
    <phone>+37069882515</phone>
    <email>jurate.navikiene@santa.lt</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arunas Liubsys, MD</last_name>
    <phone>+37052720387</phone>
    <email>arunas.liubsys@santa.lt</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vilnius University Santaros Klinikos Neonatology Center</name>
      <address>
        <city>Vilnius</city>
        <zip>08406</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jurate Navikiene, MD</last_name>
      <phone>+37069882515</phone>
      <email>jurate.navikiene@santa.lt</email>
    </contact>
  </location>
  <location_countries>
    <country>Lithuania</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 19, 2020</study_first_submitted>
  <study_first_submitted_qc>March 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2020</study_first_posted>
  <last_update_submitted>March 3, 2020</last_update_submitted>
  <last_update_submitted_qc>March 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>near-infrared spectroscopy</keyword>
  <keyword>preterm infant</keyword>
  <keyword>echocardiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ductus Arteriosus, Patent</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

